TrialThe Prostate2012

Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.

Daniel J Zabransky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.